Why Duke Opted Out of Becoming a 503B

By Gina Shaw
Duke University Health System has been doing bulk nonsterile compounding since well before there was a USP Chapter <797>, and certainly long before the FDA developed the draft guidance that established 503B compounding pharmacies in 2014.